HT-1376 In Vivo Anti-Tumor Efficacy Assay (CAT#: ITS-1022-YF2939)

HT-1376

Human

HT-1376 is an epithelial-like cell isolated from the urinary bladder of a White, 58-year-old, female with carcinoma. This cell line was deposited by S Rasheed and can be used for immuno-oncology research.

Urinary Bladder Cancer

Oncology

In Vivo Anti-Tumor Efficacy Assay

HT-1376-cell based In Vivo Anti-Tumor Efficacy Assay

After positive anti-tumor efficacy data is concluded using in vitro assays, we can start to initiate in vivo anti-tumor efficacy studies. Creative Biolabs offers a wide variety of PDX or CDX models to facilitate the efficacy studies. This assy will be used to evaluate the anti-tumor efficacy of your therapeutic candidates, such as small molecules, antibodies, CARTs or other biologics. Detailed group set up and other plans will be discussed according to your specific requirements.

Oncology In Vivo Assays